86 research outputs found
Magnetic anisotropy determination and magnetic hyperthermia properties of small Fe nanoparticles in the superparamagnetic regime
We report on the magnetic and hyperthermia properties of iron nanoparticles
synthesized by organometallic chemistry. They are 5.5 nm in diameter and
display a saturation magnetization close to the bulk one. Magnetic properties
are dominated by the contribution of aggregates of nanoparticles with respect
to individual isolated nanoparticles. Alternative susceptibility measurements
are been performed on a low interacting system obtained after eliminating the
aggregates by centrifugation. A quantitative analysis using the Gittleman s
model allow a determination of the effective anisotropy Keff = 1.3 * 10^5
J.m^{-3}, more than two times the magnetocristalline value of bulk iron.
Hyperthermia measurements are performed on agglomerates of nanoparticles at a
magnetic field up to 66 mT and at frequencies in the range 5-300 kHz. Maximum
measured SAR is 280 W/g at 300 kHz and 66 mT. Specific absorption rate (SAR)
displays a square dependence with the magnetic field below 30 mT but deviates
from this power law at higher value. SAR is linear with the applied frequency
for mu_0H=19 mT. The deviations from the linear response theory are discussed.
A refined estimation of the optimal size of iron nanoparticles for hyperthermia
applications is provided using the determined effective anisotropy value
Magnetic hyperthermia in single-domain monodisperse FeCo nanoparticles: Evidences for Stoner-Wohlfarth behaviour and large losses
We report on hyperthermia measurements on a colloidal solution of 15 nm
monodisperse FeCo nanoparticles (NPs). Losses as a function of the magnetic
field display a sharp increase followed by a plateau, which is what is expected
for losses of ferromagnetic single-domain NPs. The frequency dependence of the
coercive field is deduced from hyperthermia measurement and is in quantitative
agreement with a simple model of non-interacting NPs. The measured losses (1.5
mJ/g) compare to the highest of the literature, though the saturation
magnetization of the NPs is well below the bulk one.Comment: 14 pages, 3 figure
Tuning complex shapes in Pt(0) nanoparticles : from cubic dendrites to five-fold stars
A platinum star performance: Quasi-single-crystalline Pt nanoparticles with peculiar morphologiesâcubic dendrites, planar tripods, and fivefold starsâwere synthesized in high yield. Shape selectivity was achieved by finely tuning the growth kinetics under a dihydrogen atmosphere
The 20 years of PROSITE
PROSITE consists of documentation entries describing protein domains, families and functional sites, as well as associated patterns and profiles to identify them. It is complemented by ProRule, a collection of rules based on profiles and patterns, which increases the discriminatory power of profiles and patterns by providing additional information about functionally and/or structurally critical amino acids. In this article, we describe the implementation of a new method to assign a status to pattern matches, the new PROSITE web page and a new approach to improve the specificity and sensitivity of PROSITE methods. The latest version of PROSITE (release 20.19 of 11 September 2007) contains 1319 patterns, 745 profiles and 764 ProRules. Over the past 2 years, about 200 domains have been added, and now 53% of UniProtKB/Swiss-Prot entries (release 54.2 of 11 September 2007) have a PROSITE match. PROSITE is available on the web at: http://www.expasy.org/prosit
The 20 years of PROSITE
PROSITE consists of documentation entries describing protein domains, families and functional sites, as well as associated patterns and profiles to identify them. It is complemented by ProRule, a collection of rules based on profiles and patterns, which increases the discriminatory power of profiles and patterns by providing additional information about functionally and/or structurally critical amino acids. In this article, we describe the implementation of a new method to assign a status to pattern matches, the new PROSITE web page and a new approach to improve the specificity and sensitivity of PROSITE methods. The latest version of PROSITE (release 20.19 of 11 September 2007) contains 1319 patterns, 745 profiles and 764 ProRules. Over the past 2 years, about 200 domains have been added, and now 53% of UniProtKB/Swiss-Prot entries (release 54.2 of 11 September 2007) have a PROSITE match. PROSITE is available on the web at: http://www.expasy.org/prosite/
Large specific absorption rates in the magnetic hyperthermia properties of metallic iron nanocubes
We report on the magnetic hyperthermia properties of chemically synthesized
ferromagnetic 11 and 16 nm Fe(0) nanoparticles of cubic shape displaying the
saturation magnetization of bulk iron. The specific absorption rate measured on
16 nm nanocubes is 1690+-160 W/g at 300 kHz and 66 mT. This corresponds to
specific losses-per-cycle of 5.6 mJ/g, largely exceeding the ones reported in
other systems. A way to quantify the degree of optimization of any system with
respect to hyperthermia applications is proposed. Applied here, this method
shows that our nanoparticles are not fully optimized, probably due to the
strong influence of magnetic interactions on their magnetic response. Once
protected from oxidation and further optimized, such nano-objects could
constitute efficient magnetic cores for biomedical applications requiring very
large heating power
Nature of the bonding in metal-silane Ï-complexes
The nature of metal silane Ï-bond interaction has been investigated in several key systems by a range of experimental and computational techniques. The structure of [CpâČMn(CO)2(η2-HSiHPh2)] 1 has been determined by single crystal neutron diffraction, and the geometry at the Si atom is shown to approximate a trigonal bipyramid; salient bond distances and angles are MnâH(1) 1.575(14), SiâH(1) 1.806(14), SiâH(2) 1.501(13) Ă
, and H(1)âSiâH(2) 148.5(8)°. This complex is similar to [CpâČMn(CO)2(η2-HSiFPh2)] 2, whose structure and bonding characteristics have recently been determined by charge density studies based on high-resolution X-ray and neutron diffraction data. The geometry at the Si atom in these Ï-bond complexes is compared with that in other systems containing hypercoordinate silicon. The MnâH distances for 1 and 2 in solution have been estimated using NMR T1 relaxation measurements, giving a value of 1.56(3) Ă
in each case, in excellent agreement with the distances deduced from neutron diffraction. Density functional theory calculations have been employed to explore the bonding in the MnâHâSi unit in 1 and 2 and in the related system [CpâČMn(CO)2(η2-HSiCl3)] 3. These studies support the idea that the oxidative addition of a silane ligand to a transition metal center may be described as an asymmetric process in which the MnâH bond is formed at an early stage, while both the establishment of the MnâSi bond and also the activation of the η2-coordinated SiâH moiety are controlled by the extent of Mn â Ï*(XâSiâH) back-donation, which increases with increasing electron-withdrawing character of the X substituent trans to the metal-coordinated SiâH bond. This delocalized molecular orbital (MO) approach is complemented and supported by combined experimental and theoretical charge density studies: the source function S(r,Ω), which provides a measure of the relative importance of each atomâs contribution to the density at a specific reference point r, clearly shows that all three atoms of the Mn(η2-SiH) moiety contribute to a very similar extent to the density at the MnâSi bond critical point, in pleasing agreement with the MO model. Hence, we advance a consistent and unifying concept which accounts for the degree of SiâH activation in these silane Ï-bond complexes
Autoantibodies against type I IFNs in patients with critical influenza pneumonia
In an international cohort of 279 patients with hypoxemic influenza pneumonia, we identified 13 patients (4.6%) with autoantibodies neutralizing IFN-alpha and/or -omega, which were previously reported to underlie 15% cases of life-threatening COVID-19 pneumonia and one third of severe adverse reactions to live-attenuated yellow fever vaccine. Autoantibodies neutralizing type I interferons (IFNs) can underlie critical COVID-19 pneumonia and yellow fever vaccine disease. We report here on 13 patients harboring autoantibodies neutralizing IFN-alpha 2 alone (five patients) or with IFN-omega (eight patients) from a cohort of 279 patients (4.7%) aged 6-73 yr with critical influenza pneumonia. Nine and four patients had antibodies neutralizing high and low concentrations, respectively, of IFN-alpha 2, and six and two patients had antibodies neutralizing high and low concentrations, respectively, of IFN-omega. The patients' autoantibodies increased influenza A virus replication in both A549 cells and reconstituted human airway epithelia. The prevalence of these antibodies was significantly higher than that in the general population for patients 70 yr of age (3.1 vs. 4.4%, P = 0.68). The risk of critical influenza was highest in patients with antibodies neutralizing high concentrations of both IFN-alpha 2 and IFN-omega (OR = 11.7, P = 1.3 x 10(-5)), especially those <70 yr old (OR = 139.9, P = 3.1 x 10(-10)). We also identified 10 patients in additional influenza patient cohorts. Autoantibodies neutralizing type I IFNs account for similar to 5% of cases of life-threatening influenza pneumonia in patients <70 yr old
Burden of intracerebral haemorrhage in Europe: forecasting incidence and mortality between 2019 and 2050
Background: Anticipating the burden of intracerebral haemorrhage is crucial for proactive management and building resilience against future health challenges. Prior forecasts are based on population demography and to a lesser extent epidemiological trends. This study aims to utilise selected modifiable risk factors and socio-demographic indicators to forecast the incidence and mortality of intracerebral haemorrhage in Europe between 2019 and 2050. Methods: Three intracerebral haemorrhage risk factors identified in the Global Burden of Diseases, Injuries, and Risk Factors study (GBD 2019)âhigh systolic blood pressure, high fasting plasma glucose, and high body mass indexâwere utilised to predict the risk-attributable fractions between 2019 and 2050. Disease burden not attributable to these risk factors was then forecasted using time series models (autoregressive integrated moving average [ARIMA]), incorporating the Socio-demographic Index (SDI) as an external predictor. The optimal parameters of ARIMA models were selected for each age-sex-country group based on the Akaike Information Criterion (AIC). Different health scenarios were constructed by extending the past 85th and 15th percentiles of annualised rates of change in risk factors and SDI across all location-years, stratified by age and sex groups. A decomposition analysis was performed to assess the relative contributions of population size, age composition, and intracerebral haemorrhage risk on the projected changes. Findings: Compared with observed figures in 2019, our analysis predicts an increase in the burden of intracerebral haemorrhage in Europe in 2050, with a marginal rise of 0.6% (95% uncertainty interval [UI], â7.4% to 9.6%) in incident cases and an 8.9% (â2.8% to 23.6%) increase in mortality, reaching 141.2 (120.6â166.5) thousand and 144.2 (122.9â172.2) thousand respectively. These projections may fluctuate depending on trajectories of the risk factors and SDI; worsened trends could result in increases of 16.7% (8.7%â25.3%) in incidence and 31.2% (17.7%â48%) in mortality, while better trajectories may lead to a 10% (16.4%â2.3%) decrease in intracerebral haemorrhage cases with stabilised mortality. Individuals aged â„80 years are expected to contribute significantly to the burden, comprising 62.7% of the cases in 2050, up from 40% in 2019, and 72.5% of deaths, up from 50.5%. Country-wide variations were noted in the projected changes, with decreases in the standardised rates across all nations but varying crude rates. The largest relative reductions in counts for both incidence and mortality are expected in Latvia, Bulgaria, and Hungaryâranging from â38.2% to â32.4% and â37.3% to â30.2% respectively. In contrast, the greatest increases for both measures were forecasted in Ireland (45.7% and 74.4%), Luxembourg (45% and 70.7%), and Cyprus (44.5% and 74.2%). The modelled increase in the burden of intracerebral haemorrhage could largely be attributed to population ageing. Interpretation: This study provides a comprehensive forecast of intracerebral haemorrhage in Europe until 2050, presenting different trajectories. The potential increase in the number of people experiencing and dying from intracerebral haemorrhage could have profound implications for both caregiving responsibilities and associated costs. However, forecasts were divergent between different scenarios and among EU countries, signalling the pivotal role of public health initiatives in steering the trajectories. Funding: TheEuropean Union's Horizon 2020 Research and Innovation Programme under grant agreement No.754517. TheNational Institute for Health and Care Research (NIHR) under its Programme Grants forApplied Research (NIHR202339)
- âŠ